Cargando…

PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling

In the liver, insulin-mediated activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway is at the core of metabolic control. Multiple PI3K and Akt isoenzymes are found in hepatocytes and whether isoform-selective interplays exist is currently unclear. Here we report that insulin signalling...

Descripción completa

Detalles Bibliográficos
Autores principales: Braccini, Laura, Ciraolo, Elisa, Campa, Carlo C., Perino, Alessia, Longo, Dario L., Tibolla, Gianpaolo, Pregnolato, Marco, Cao, Yanyan, Tassone, Beatrice, Damilano, Federico, Laffargue, Muriel, Calautti, Enzo, Falasca, Marco, Norata, Giuseppe D., Backer, Jonathan M., Hirsch, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Pub. Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479417/
https://www.ncbi.nlm.nih.gov/pubmed/26100075
http://dx.doi.org/10.1038/ncomms8400
_version_ 1782378004182204416
author Braccini, Laura
Ciraolo, Elisa
Campa, Carlo C.
Perino, Alessia
Longo, Dario L.
Tibolla, Gianpaolo
Pregnolato, Marco
Cao, Yanyan
Tassone, Beatrice
Damilano, Federico
Laffargue, Muriel
Calautti, Enzo
Falasca, Marco
Norata, Giuseppe D.
Backer, Jonathan M.
Hirsch, Emilio
author_facet Braccini, Laura
Ciraolo, Elisa
Campa, Carlo C.
Perino, Alessia
Longo, Dario L.
Tibolla, Gianpaolo
Pregnolato, Marco
Cao, Yanyan
Tassone, Beatrice
Damilano, Federico
Laffargue, Muriel
Calautti, Enzo
Falasca, Marco
Norata, Giuseppe D.
Backer, Jonathan M.
Hirsch, Emilio
author_sort Braccini, Laura
collection PubMed
description In the liver, insulin-mediated activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway is at the core of metabolic control. Multiple PI3K and Akt isoenzymes are found in hepatocytes and whether isoform-selective interplays exist is currently unclear. Here we report that insulin signalling triggers the association of the liver-specific class II PI3K isoform γ (PI3K-C2γ) with Rab5-GTP, and its recruitment to Rab5-positive early endosomes. In these vesicles, PI3K-C2γ produces a phosphatidylinositol-3,4-bisphosphate pool specifically required for delayed and sustained endosomal Akt2 stimulation. Accordingly, loss of PI3K-C2γ does not affect insulin-dependent Akt1 activation as well as S6K and FoxO1-3 phosphorylation, but selectively reduces Akt2 activation, which specifically inhibits glycogen synthase activity. As a consequence, PI3K-C2γ-deficient mice display severely reduced liver accumulation of glycogen and develop hyperlipidemia, adiposity as well as insulin resistance with age or after consumption of a high-fat diet. Our data indicate PI3K-C2γ supports an isoenzyme-specific forking of insulin-mediated signal transduction to an endosomal pool of Akt2, required for glucose homeostasis.
format Online
Article
Text
id pubmed-4479417
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Pub. Group
record_format MEDLINE/PubMed
spelling pubmed-44794172015-09-11 PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling Braccini, Laura Ciraolo, Elisa Campa, Carlo C. Perino, Alessia Longo, Dario L. Tibolla, Gianpaolo Pregnolato, Marco Cao, Yanyan Tassone, Beatrice Damilano, Federico Laffargue, Muriel Calautti, Enzo Falasca, Marco Norata, Giuseppe D. Backer, Jonathan M. Hirsch, Emilio Nat Commun Article In the liver, insulin-mediated activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway is at the core of metabolic control. Multiple PI3K and Akt isoenzymes are found in hepatocytes and whether isoform-selective interplays exist is currently unclear. Here we report that insulin signalling triggers the association of the liver-specific class II PI3K isoform γ (PI3K-C2γ) with Rab5-GTP, and its recruitment to Rab5-positive early endosomes. In these vesicles, PI3K-C2γ produces a phosphatidylinositol-3,4-bisphosphate pool specifically required for delayed and sustained endosomal Akt2 stimulation. Accordingly, loss of PI3K-C2γ does not affect insulin-dependent Akt1 activation as well as S6K and FoxO1-3 phosphorylation, but selectively reduces Akt2 activation, which specifically inhibits glycogen synthase activity. As a consequence, PI3K-C2γ-deficient mice display severely reduced liver accumulation of glycogen and develop hyperlipidemia, adiposity as well as insulin resistance with age or after consumption of a high-fat diet. Our data indicate PI3K-C2γ supports an isoenzyme-specific forking of insulin-mediated signal transduction to an endosomal pool of Akt2, required for glucose homeostasis. Nature Pub. Group 2015-06-23 /pmc/articles/PMC4479417/ /pubmed/26100075 http://dx.doi.org/10.1038/ncomms8400 Text en Copyright © 2015, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Braccini, Laura
Ciraolo, Elisa
Campa, Carlo C.
Perino, Alessia
Longo, Dario L.
Tibolla, Gianpaolo
Pregnolato, Marco
Cao, Yanyan
Tassone, Beatrice
Damilano, Federico
Laffargue, Muriel
Calautti, Enzo
Falasca, Marco
Norata, Giuseppe D.
Backer, Jonathan M.
Hirsch, Emilio
PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling
title PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling
title_full PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling
title_fullStr PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling
title_full_unstemmed PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling
title_short PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling
title_sort pi3k-c2γ is a rab5 effector selectively controlling endosomal akt2 activation downstream of insulin signalling
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479417/
https://www.ncbi.nlm.nih.gov/pubmed/26100075
http://dx.doi.org/10.1038/ncomms8400
work_keys_str_mv AT braccinilaura pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling
AT ciraoloelisa pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling
AT campacarloc pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling
AT perinoalessia pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling
AT longodariol pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling
AT tibollagianpaolo pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling
AT pregnolatomarco pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling
AT caoyanyan pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling
AT tassonebeatrice pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling
AT damilanofederico pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling
AT laffarguemuriel pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling
AT calauttienzo pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling
AT falascamarco pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling
AT noratagiusepped pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling
AT backerjonathanm pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling
AT hirschemilio pi3kc2gisarab5effectorselectivelycontrollingendosomalakt2activationdownstreamofinsulinsignalling